Johnson & Johnson will not be allowed to pursue an interlocutory appeal of the Court's pre-emption decision, which allows Tylenol autism lawsuits to move forward over adequacy of the acetaminophen pregnancy warnings
Judge presiding over all Tylenol autism lawsuits invited the FDA to give their opinion on proposed pregnancy warnings for acetaminophen drugs.
It is well known that children who receive an early autism diagnosis are more likely to receive needed assistance and resources to reduce effects on their life.
More healthcare workers need to be made aware of the link between Tylenol and Stevens-Johnson Syndrome, the researchers warn.
Trial judge determined last month that Tylenol autism and ADHD lawsuits are not preempted by federal law, and the drug maker seeks an immediate appeal of the decision before the litigation moves forward.
The ruling means that Tylenol lawsuits over the failure to warn about the risk of autism and ADHD lawsuits can move forward in the federal court system
The CDC warns that acetaminophen, ibuprofin and other household medications are easily available and sold in large quantities, making them accessible to teens with suicidal thoughts.
Plaintiffs say the invitation is unnecessary, saying their cases should not depend on proposed acetaminophen pregnancy warnings submitted earlier this month.
Federal judge presiding over lawsuits brought by families nationwide asked plaintiffs' lawyers to propose Tylenol pregnancy warnings that should have been added to the painkiller acetaminophen
Pregnant women exposed to the highest levels of lithium in drinking water had a nearly 50% increased chance of having a child diagnosed with autism.
